CARDIOVASCULAR GENOMIC MEDICINE
Circulating Endothelial Cells in Cardiovascular Disease
Christopher J. Boos, MRCP,
Gregory Y.H. Lip, MD and
Andrew D. Blann, PhD*
Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom
Manuscript received December 13, 2005;
revised manuscript received February 8, 2006,
accepted February 14, 2006.
* Reprint requests and correspondence: Dr. Andrew D. Blann, University Department of Medicine City Hospital, Haemostasis, Thrombosis, and Vascular Biology, Dudley Road, Birmingham B18 7QH, United Kingdom (Email: a.blann{at}bham.ac.uk).
Quantification of circulating endothelial cells (CECs) in peripheral blood is developing as a novel and reproducible method of assessing endothelial damage/dysfunction. The CECs are thought to be mature cells that have detached from the intimal monolayer in response to endothelial injury and are a different cell population to endothelial progenitor cells (EPCs). The EPCs are nonleukocytes derived from the bone marrow that are believed to have proliferative potential and may be important in vascular regeneration. Currently accepted methods of CEC quantification include the use of immunomagnetic bead separation (with cell counting under fluorescence microscopy) and flow cytometry. Several recent studies have shown increased numbers of CECs in cardiovascular disease and its risk factors, such as unstable angina, acute myocardial infarction, stroke, diabetes mellitus, and critical limb ischemia, but no change in stable intermittent claudication, essential hypertension, or atrial fibrillation. Furthermore, CEC quantification at 48 h after acute myocardial infarction has been shown to be an accurate predictor of major adverse coronary events and death at both 1 month and 1 year. This article presents an overview of the pathophysiology of CECs in the setting of cardiovascular disease and a brief comparison with EPCs.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | CAD = coronary artery disease | | CEC = circulating endothelial cell | | CVD = cardiovascular disease | | EPC = endothelial progenitor cell | | FMD = flow-mediated dilatation | | MI = myocardial infarction | | PVD = peripheral vascular disease | | VEGFR = vascular endothelial growth factor receptor | | vWf = von Willebrand factor |
|
This article has been cited by other articles:
|
|
|
|
 
S. B. Damani and E. J. Topol
Emerging Genomic Applications in Coronary Artery Disease
J. Am. Coll. Cardiol. Intv.,
May 1, 2011;
4(5):
473 - 482.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-C. Chen, T.-P. Lee, Y.-C. Pan, C.-L. Chiang, C.-L. Chen, Y.-H. Yang, B.-L. Chiang, H. Lee, and A. M. Wo
Detection of Circulating Endothelial Cells via a Microfluidic Disk
Clin. Chem.,
April 1, 2011;
57(4):
586 - 592.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. V. Desouza, F. G. Hamel, K. Bidasee, and K. O'Connell
Role of Inflammation and Insulin Resistance in Endothelial Progenitor Cell Dysfunction
Diabetes,
April 1, 2011;
60(4):
1286 - 1294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shantsila, G. Dwivedi, E. Shantsila, M. Butt, D. G. Beevers, and G. Y. H. Lip
Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension
Hypertension,
March 1, 2011;
57(3):
490 - 496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. O'Rourke, M. E. Safar, and V. Dzau
The Cardiovascular Continuum extended: Aging effects on the aorta and microvasculature
Vascular Medicine,
December 1, 2010;
15(6):
461 - 468.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Rudez, H. J. Duckers, and M. L. Simoons
Clopidogrel and Endothelial Injury After Percutaneous Coronary Interventions: Beyond the Antiplatelet Effects
J. Am. Coll. Cardiol.,
September 21, 2010;
56(13):
1032 - 1033.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. P. Fadini and A. Avogaro
Cell-based methods for ex vivo evaluation of human endothelial biology
Cardiovasc Res,
July 1, 2010;
87(1):
12 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. John, S. Panch, J. Hrabe, P. Wei, A. Solovey, L. Joyce, and R. Hebbel
Activation of Endothelial and Coagulation Systems in Left Ventricular Assist Device Recipients
Ann. Thorac. Surg.,
October 1, 2009;
88(4):
1171 - 1179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Plouffe, T. Kniazeva, J. E. Mayer Jr., S. K. Murthy, and V. L. Sales
Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine
FASEB J,
October 1, 2009;
23(10):
3309 - 3314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Elshal, A. Abdelaziz, A. Abbas, K. Mahmoud, H. Fathy, S. E. Mongy, S. El-Basyuoni, H. Ahmed, and P. McCoy
Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair
Nephrol. Dial. Transplant.,
May 1, 2009;
24(5):
1495 - 1499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Leone, M. Valgimigli, M. B. Giannico, V. Zaccone, M. Perfetti, D. D'Amario, A. G. Rebuzzi, and F. Crea
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells
Eur. Heart J.,
April 2, 2009;
30(8):
890 - 899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pirro, F. Bagaglia, L. Paoletti, R. Razzi, and M. R. Mannarino
Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction
Therapeutic Advances in Cardiovascular Disease,
October 1, 2008;
2(5):
329 - 339.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Mannarino and M. Pirro
Endothelial Injury and Repair: A Novel Theory for Atherosclerosis
Angiology,
August 1, 2008;
59(2_suppl):
69S - 72S.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Surdacki, E. Marewicz, E. Wieteska, G. Szastak, T. Rakowski, E. Wieczorek-Surdacka, D. Dudek, J. Pryjma, and J. S. Dubiel
Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina
Nephrol. Dial. Transplant.,
July 1, 2008;
23(7):
2265 - 2273.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Yao, Z.-H. Liu, C. Zheng, X. Zhang, H. Chen, C. Zeng, and L.-S. Li
Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis
Rheumatology,
April 1, 2008;
47(4):
432 - 436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Pitt
N-terminal pro-B-type natriuretic peptide concentrations >=100 ng/l increased risk of all-cause mortality
Evid. Based Med.,
February 1, 2008;
13(1):
26 - 26.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Boos, B. Balakrishnan, S. Jessani, A. D. Blann, and G. Y. H. Lip
Effects of Percutaneous Coronary Intervention on Peripheral Venous Blood Circulating Endothelial Cells and Plasma Indices of Endothelial Damage/Dysfunction
Chest,
December 1, 2007;
132(6):
1920 - 1926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Boos, D. A. Lane, M. Karpha, D. G. Beevers, R. Haynes, and G. Y. H. Lip
Circulating Endothelial Cells, Arterial Stiffness, and Cardiovascular Risk Stratification in Hypertension
Chest,
November 1, 2007;
132(5):
1540 - 1547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. Y. Goon, T. Watson, and G. Y. H. Lip
Circulating Endothelial Cells in Obstructive Sleep Apnea: An Important Methodological Lesson
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1346 - 1346.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Boos, S. K. Soor, D. Kang, and G. Y.H. Lip
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes
Eur. Heart J.,
May 1, 2007;
28(9):
1092 - 1101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
